期刊文献+

奥美拉唑联合奥曲肽治疗肝硬化并发上消化道大出血的疗效观察 被引量:8

下载PDF
导出
摘要 目的探讨奥美拉唑联合奥曲肽治疗肝硬化并发上消化道大出血的临床疗效。方法将肝硬化并发上消化道大出血患者52例随机分为治疗组27例和对照组25例。治疗组采用奥美拉唑联合奥曲肽治疗,对照组单用奥曲肽治疗。治疗后观察2组临床疗效及止血时间。结果治疗组显效率与总有效率均高于对照组,且平均止血时间为(14±6)h明显小于对照组的(20±5)h,差异均有统计学意义(P<0.05)。结论奥美拉唑联合奥曲肽治疗肝硬化并发上消化道大出血,止血迅速,疗效显著,且不良反应少,值得临床推广应用。
出处 《临床合理用药杂志》 2010年第14期58-58,共1页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

二级参考文献15

  • 1罗忠金,邬柏林,刘晶美.奥曲肽治疗食管胃底静脉曲张破裂出血的临床效果[J].实用临床医学(江西),2005,6(11):55-56. 被引量:2
  • 2李雪飞.食道静脉曲张破裂出血不同治疗方法的对照研究[J].中国社区医师(医学专业),2006,8(4):27-28. 被引量:15
  • 3刘菲,陆玮.生长抑素对肝硬化病人门脉血流动力学的影响[J].中华消化杂志,1996,16(6):367-368. 被引量:58
  • 4Freitas DS, Sofia C, Pontes JM, et al. Octreotide in acute bleeding esophageal varices: a prospective randomized study.Hepatogastroenterology, 2000, 47:1310-1314. 被引量:1
  • 5Feu ET, Del Arbol, Banares R, et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology, 1996,111 : 1291-1299. 被引量:1
  • 6Comar KM, Sanyal AJ. Portal hypertension bleeding.Gastroenterol Clin North Am, 2003, 32: 1079-1105. 被引量:1
  • 7Zaman A. Current management of esophageal varices. Curr Treat Options Gastroenterol, 2003, 6: 499-457. 被引量:1
  • 8Yillanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology, 2001, 121:110-117. 被引量:1
  • 9Bildozola M, Kravetz D, Argonz T, et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol, 2000, 35 : 419-425. 被引量:1
  • 10UK guidelines on the management of variceal haemorrhage in cirrhotic patients.Gut,2000,46:1-15. 被引量:1

共引文献90

同被引文献43

  • 1夏穗生.肝硬化门脉高压症并发大呕血的外科诊治[J].现代实用医学,2006,18(9):613-615. 被引量:1
  • 2陈灏珠.实用内科学[M].北京:人民卫生出版社,1973:585. 被引量:77
  • 3Groszmann RJ. Garcia Tsal G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N Engl J Med,2005,353 (21) : 2254 - 2261. 被引量:1
  • 4Hiqaki N,Characteristic endoscopifeatures or portal hypertensive enteropathy[J].J Gastroenterol,2012,12(1):178. 被引量:1
  • 5Grabc zewska Z,Bialoszynski T,Szymanski P,et al.The effect of trimetazidine added to maximal anti-sichemic therapy in patientswith advanced coronary artery disease[J].Cardiol J,2012,19(3):55-56. 被引量:1
  • 6Bildozola M,Kravetz D,Argonz T,et al.Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients.A prospective,multicentric,and randomized clinical trial[J].Scand J Gastroenterol,2010,35(4):419-425. 被引量:1
  • 75 Shah HA,Mumtaz K,Jafri W,et al.Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastrooesophageal variceal hemorrhage[J].J Ayub Med coll Abbottabad,2011,17(1):10-14. 被引量:1
  • 8Marazzi G,Gebara O,Vitale C,et al.Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy[J].Adv Ther,2011,8(25):189-190. 被引量:1
  • 9徐捷.急性消化道大出血的临床治疗方法研究[J].现代医药卫生,2008,24(13):1958-1959. 被引量:3
  • 10菅志远,王好,周平,兰明银,江斌.门脉高压症上消化道大出血手术时机的探讨[J].肝胆外科杂志,2008,16(4):269-271. 被引量:1

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部